Thomas A. Ollila, MD¹, Rashida Taher, PA^2*, Stephen Grado, MD^3* and Adam J. Olszewski, MD⁴

¹Lifespan Cancer Institute, Brown University, Providence, RI
²Lifespan Cancer Institute, Providence, RI
³Brown Alpert School of Medicine, Providence, RI
⁴Division of Hematology/Oncology, Brown University, Providence, RI

Prokop Vodicka^1*, Katerina Benesova, MD, CSc.^2*, Andrea Janikova, assoc. prof., MD, PhD^3*, David Belada, assoc. prof., MD, PhD^4*, Heidi Mocikova, MD, Ph.D.^5*, Jan Pirnos, MD^6*, Vit Prochazka, Prof., MD, PhD^7*, Juraj Duras, MD^8*, Katerina Kopeckova, MD, PhD^9*, Katerina Steinerova, MD^10*, Petra Blahovcova, Mgr^11*, Vit Campr, MD^12*, Pavel Klener Jr., Prof., MD, PhD^1*, Alice Sykorova, MD, PhD^13* and Marek Trneny, MD¹⁴

¹First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
²1st Department Medicine, 1st Faculty of Medicine, Charles University, General Hospital, Prague, CZE
³Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
⁴Fourth Department of Internal Medicine – Hematology, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
⁵Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
⁶Department of Oncology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic
⁷Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
⁸Department of Hematology, Medical Faculty of the Ostrava University and University Hospital, Ostrava, Czech Republic
⁹Department of Oncology of the 2nd Faculty of Medicine of Charles University and University Hospital in Motol, Prague, Czech Republic
¹⁰Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
¹¹Data Centre, Czech Lymphoma Study Group, Prague, Czech Republic
¹²Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
¹³Fourth Department of Internal Medicine – Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Kralove, Hradec Kralove, CZE
¹⁴First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic

Maegan Ford, MD, MPH¹, Evelyn Orlando, MD², Zhezhen Jin, PhD^3*, Andrew H. Lipsky, MD⁴, Ahmed Sawas, MD⁵, Barbara Pro, MD⁵ and Jennifer E. Amengual, MD⁵

¹Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
²Internal Medicine Residency Program, Columbia University Medical Center, New York, NY
³Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY
⁴Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁵Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

Star Ye, MD¹, Christian Harmon, MD^2*, Nadia Anabtawi, BS^3*, Clare Ubersax, BS^2*, Abigail Tucker, MSPH^2*, Gaurav Goyal, MD¹, Lauren Shea, MD^1*, Mayur Narkhede, MBBS¹, Amitkumar Mehta, MD¹, Purnima Singh, PhD, MSc², Grant Williams, MD, MPH^1*, Smita Bhatia, MD, MPH² and Smith Giri, MD, MHS²

¹Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL

Esther Bronwyn Ting^1*, Sahar Khan, FRCPath, MD^2*, Manjula Maganti, MSc^3*, Sita Bhella, M.D., MSc^4*, Michael Crump⁴, David C. Hodgson, MD, MPH, FRCPC^5*, Robert Kridel, MD⁴, Vishal Kukreti, MD, FRCP, MSc⁴, John Kuruvilla, MD⁴, Danielle Rodin, MD, MPH^5*, Richard Tsang, MD, FRCPC^5* and Anca Prica, MD, MSc⁴

¹Nepean Hospital, Nepean Blue Mountains Local Health District, Sydney, NSW, Australia
²Windsor Regional Cancer Centre, Windsor, ON, CAN
³Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
⁵Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Pere Barba, MD^1*, Marta Ligero^2*, Cecilia Carpio, MD^3*, Maria Balaguer^2*, Víctor Navarro Garcés^4*, Sabela Bobillo, MD, PhD^3*, Francisco Beas^5*, Pau Abrisqueta, MD, PhD^3*, Roser Sala^2*, Francesc Bosch, MD, PhD⁶, Gloria Iacoboni, MD^7*, Marc Simo, MD^8* and Raquel Perez-Lopez^2*

¹Department of Hematology, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
²Radiomics Unit, Vall Hebron Institute of Oncology, Barcelona, Spain
³Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
⁴Vall Hebron Institute of Oncology, BARCELONA, Spain
⁵Vall Hebron Institute of Oncology, Barcelona, Spain
⁶Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
⁷Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁸Department of Nuclear Medicine. Vall D'Hebron University Hospital, Barcelona., Barcelona, ESP

Teresa Calimeri, MD, PhD¹, Sara Steffanoni, MD^1*, Alice Laurenge, MD^2*, Christopher P. Fox^3*, Carole Soussain, MD^4*, Christian Grommes, MD⁵, Maria Chiara Tisi, MD^6*, Jesca Boot, MD^7*, Nicola Crosbie, MD^8*, Carlo Visco, MD^9*, Luca Arcaini, MD^10*, Sridhar Chaganti, MD^11*, Alvaro J. Alencar, MD¹², Daniele Armiento, MD^13*, Ilaria Romano, MD^14*, Marianna C. Sassone, MD^15*, Jorg Dietrich, MD PhD^16*, Gilad Itchaki^17*, Riccardo Bruna, MD^18*, Nicola S Fracchiolla, MD^19*, Laura Arletti, MD^20*, Adriano Venditti, MD²¹, Stephen Booth, MD^22*, Pellegrino Musto²³, Khe Hoang-Xuan, MD, PhD^2*, Tracy Batchelor, MD²⁴, Kate Cwynarski, MD^25* and Andrés José María J.M. Ferreri, MD¹⁵

¹Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
²Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France
³Department of Hematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁴Hematologie, Hôpital René Huguenin-Institut Curie, Saint-Cloud, Paris, France
⁵Department of Medicine, Neuro-Oncology Service, Memorial Sloan Kettering Cancer, New York, NY
⁶Division of Hematology, Ospedale San Bortolo, Vicenza, Italy
⁷Barking, Havering and Redbridge University Hospitals NHS Trust, London, United Kingdom
⁸Derriford Hospital, Plymouth, United Kingdom
⁹University of Verona, Verona, ITA
¹⁰Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹¹Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
¹²Miller School of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
¹³Division of Hematology, Campus Bio Medico, Roma, Italy
¹⁴Division of Hematology, Ospedale Careggi, Firenze, Italy
¹⁵Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹⁶Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA
¹⁷Institute of Hematology,, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
¹⁸Division of Hematology, Ospedale Maggiore, Novara, Italy
¹⁹Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, MILANO, Italy
²⁰Division of Hematology,, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy
²¹Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
²²NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, ENG, United Kingdom
²³Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
²⁴Department of Neurology, Brigham and Women's Hospital, Boston, MA
²⁵University College London Hospitals NHS Foundation Trust, London, United Kingdom

Mirian Brink, PhD^1*, Arie C. van der Spek, MD, MSc^2*, Koen de Heer, MD, PhD^3*, Sabina Kersting, MD, PhD^4*, Lidwine W. Tick, MD, PhD⁵, Hanneke M. van der Straaten, MD, PhD^6*, Rogier Mous^7*, Mark-David Levin⁸, Doreen te Raa, MD, PhD^9*, Michel van Gelder¹⁰, Jeanette K. Doorduijn, MD, PhD¹¹, Arnon P. Kater, MD, PhD¹², Gerwin Huls, MD PhD^13* and Mar Bellido, MD, PhD^14*

¹Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands, Utrecht, Netherlands
²Department of Internal Medicine, North-West Hospital, Alkmaar, Netherlands
³Department of Internal Medicine, Flevo Hospital, Almere, Netherlands
⁴Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
⁵Maxima Medical Center, Veldhoven, NLD
⁶Department of Internal Medicine, St. Jansdal Hospital, Harderwijk, Netherlands
⁷UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, Netherlands
⁸Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, Netherlands
⁹Department of Hematology, Hospital Gelderse Vallei, Ede, Netherlands
¹⁰Dept internal medicine, Maastricht University Medical Center, Maastricht, Netherlands
¹¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹²Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹³Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
¹⁴Department of Hematology, University Medical Center Groningen, Groningen, Netherlands

Guang-Liang Chen, MD^1*, Pin Guo, MD, PhD^2*, Shiyu Jiang, MD^3*, Juan J. Gu, MD, PhD^4,5,6, Qunling Zhang, MD, PhD^3*, Yizhen Liu, MD, PhD^3*, Junning Cao, MD^3,7,8, Xiaonan Hong, MD^9*, Rong TAO, PhD^3,10* and Fangfang Lv^3*

¹Department of Lymphoma,, Fudan University Shanghai Cancer Center, Shanghai, China
²Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, China
³Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
⁴Roswell Park Cancer Institute, Buffalo, NY
⁵Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Fudan University Shanghai Cancer Center, Shanghai, China
⁸Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China
⁹Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
¹⁰Fudan University Shanghai Cancer Center, Shanghai, Shanghai, CHN

Daisuke Nakamura, MD, PhD^*, Tomohisa Tabuchi, MD^*, Naosuke Arima, MD^*, Maiko Hayashida, MD^*, Akihiko Arai, MD^*, Makoto Yoshimitsu, MD, PhD and Kenji Ishitsuka, MD, PhD

Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan

Maegan Ford, MD, MPH¹, Evelyn Orlando, MD², Zhezhen Jin, PhD^3*, Andrew H. Lipsky, MD⁴, Ahmed Sawas, MD⁵, Barbara Pro, MD⁵ and Jennifer E. Amengual, MD⁵

¹Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
²Internal Medicine Residency Program, Columbia University Medical Center, New York, NY
³Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY
⁴Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁵Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

M. Christina Cox, MD, PhD¹, Sabrina Pelliccia, MD^2*, Paola Orlandi^3*, Arianna Di Napoli^4*, Gerardo Musuraca^5*, Caterina Patti, MD^6*, Maria Paola Bianchi^7*, Matteo Caridi^8*, Marta Banchi^3*, Roberta Battistini, MD^9*, Tiziana Lanzolla^10*, Agostino Tafuri¹¹ and Guido Bocci^3*

¹Hematology, Policlinico Tor Vergata, Rome, Italy
²Hematology, Sant’Andrea Hospital, Rome, Italy
³Pharmacology, University of Pisa, Pisa, Italy
⁴Pathology unit, Azienda Ospedaliera-Universitaria Sant'Andrea, Rome, Italy
⁵Division of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
⁶Division of Hematology, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
⁷Azienda Ospedaliera Sant'Andrea, Rome, Italy
⁸Hematology, University of Perugia, Perugia, Italy
⁹Hematology, San Camillo Hospital, Rome, Italy
¹⁰Nuclear Medicine, Azienda Ospedaliera-Universitaria Sant'Andrea, Rome, Italy
¹¹University Hospital Sant'Andrea-Sapienza, Rome, Italy

Supreet Kaur, MD¹, Qianqian Liu, PhD^2*, Joel E Michalek, PhD^2* and Adolfo Enrique Diaz Duque, MD³

¹University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
²Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
³Hematology-Oncology Division, UT Health San Antonio / Mays Cancer Center, San Antonio, TX

Ranjit Nair, MD¹, Amy Ayers, MPH^2*, Loretta J. Nastoupil, MD², Jillian R. Gunther, MD, PhD^3*, Luis Fayad, MD², Nathan H. Fowler, MD², Roberto N. Miranda, MD^4*, Fredrick B. Hagemeister, MD⁵, Hun Ju Lee, MD², Maria Alma Rodriguez, MD^6*, Raphael Steiner, MD^2*, Paolo Strati, MD², Yago Nieto, MD⁷, Jeremy L. Ramdial, MD⁸, Dai Chihara, MD², Michael L. Wang, MD², Luis E Malpica Castillo, MD^9*, Neeraj Saini, MD⁸, Preetesh Jain, MBBS, MD, DM, PhD¹⁰, Chelsea C. Pinnix, MD, PhD³, Bouthaina S. Dabaja, MD^3*, Michael R. Green, PhD¹¹, Christopher R. Flowers, MD¹², L. Jeffrey Medeiros, MD⁴, Mario L. Marques-Piubelli, MD^13*, Francisco Vega, MD, PhD¹⁴, Mansoor Noorani^15*, Sairah Ahmed, MD², Jason Westin, MD¹⁶, Sattva S. Neelapu, MD², Lei Feng, MS^17* and Swaminathan Padmanabhan Iyer, MD^2*

¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX
⁶MD Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, UTMDACC, Houston, TX
¹¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Friendswood, TX
¹²Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹³Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
¹⁵UTMDACC, Houston
¹⁶The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Hedi Bensaber, MD^1*, Emmanuel Bachy, MD, PhD^2*, David Beauvais, MD^3,4*, Remy Dulery^5*, Thomas Gastinne, MD^6*, Bruno Villemagne, MD^7*, Louise Roulin^8*, Etienne Paubelle, MD^9*, Cristina Castilla-Llorente, MD^10*, Thomas Longval, MD^11*, Elodie Gat^12*, Amandine Fayard, MD^1*, Jacques-Olivier Bay, MD, PhD¹, Steven Le Gouill, MD, PhD^13*, Roch Houot, MD, PhD^14* and Romain Guieze, MD, PhD^1*

¹Department of Hematology and Cell Therapy, Estaing University Hospital, CLERMONT-FERRAND, France
²Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
³Hématologie clinique, CHU de Lille, Lille, France
⁴Department of Hematology, University Hospital of Lille, Lille, France
⁵Service d’Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
⁶Hematology Department, Nantes University Hospital, Nantes, France
⁷Clinical Hematology, Hospital of Vendée, La Roche-sur-Yon, France
⁸Hôpital Henri Mondor, Creteil, France
⁹Service d’Hématologie Clinique et Thérapie cellulaire, Centre Hospitalier Universitaire d’Amiens, Amiens, France
¹⁰Department of hematology, Gustave Roussy Institute, Villejuif, France
¹¹Department of Hematology, Versailles Hospital, Le Chesnay-Rocquencourt, France
¹²LYSARC, The Lymphoma Academic Research Organisation, Lyon Sud Hospital, PIERRE-BENITE, France
¹³Curie Institute, Paris, France
¹⁴Department of Hematology, University Hospital of Rennes, Rennes, FRA

Peiqi Zhao^1*, Lei Zhu^1*, Lanfang Li^1*, Shiyong Zhou^2*, Lihua Qiu^2*, Kai Fu³ and Huilai Zhang, M.D.^1*

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
³Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Christian Grommes, MD¹, Anna Piotrowski, MD^2*, Elena Pentsova, MD^2*, Igor Gavrilovic, MD^3*, Jacqueline B Stone, MD^3*, Andrew Lin, MD^2*, Venissala Wongchai^2*, Juli T Madzsar^3*, Rachna Malani^2*, Craig Nolan, MD^2*, Jasmine Francis^2*, Lisa DeAngelis, MD^4*, Lauren Schaff, MD^3* and Ingo K Mellinghoff, MD^5*

¹Department of Medicine, Neuro-Oncology Service, Memorial Sloan Kettering Cancer, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY
⁵Memorial Sloan-Kettering Cancer Center, New York, NY

Masahiro Akimoto, MD^1*, Takuya Miyazaki, MD^1*, Hiroyuki Takahashi, MD^2*, Yusuke Saigusa, PhD^3*, Takaaki Takeda, MD^2*, Yuto Hibino, MD^2*, Mayumi Tokunaga, MD^2*, Takuma Ohashi, MD^4*, Ayako Matsumura, MD^1*, Haruka Teshigawara, MD^4*, Taisei Suzuki, MD^5*, Hiroshi Teranaka, MD^4*, Yuki Nakajima, MD^1*, Kenji Matsumoto, MD^4*, Chizuko Hashimoto, MD^6*, Katsumichi Fujimaki, MD, PhD^5*, Hiroyuki Fujita, MD⁷, Rika Sakai², Shin Fujisawa, MD^1* and Hideaki Nakajima, MD⁴

¹Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
²Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
³Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan
⁴Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
⁵Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan
⁶Department of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan
⁷Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan

Anthea Peters, MD¹, Grzegorz S. Nowakowski, MD², Rosy Dabas, PhD^3*, Theresa Amoloja, MPH^4*, Zhenyi Xue, PhD^4*, Caroline Koch, PhD^3*, Eva E. Waltl, PhD^5* and Isabelle Fleury, MD⁶

¹Department of Oncology, University of Alberta, Edmonton, AB, Canada
²Division of Hematology, Mayo Clinic, Rochester, MN
³Incyte Biosciences Canada, Pointe-Claire, QC, Canada
⁴Incyte Corporation, Wilmington, DE
⁵MorphoSys AG, Planegg, Germany
⁶Maisonneuve-Rosemont Hospital, Montreal University, Montreal, QC, Canada

NA Zhang^1* and Kai Hu, M.D., Ph.D.^2*

¹Beijing Boren Hospital, Beijing, AL, China
²Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China

Ofrat Beyar Katz^1,2, Chava Perry, MD, PhD^1,3*, Efrat Luttwak, MD^1,3*, Inbal Sdayoor^1*, Yael Bar-On, MD^1,2*, Odelia Amit, MD^1,2*, Ronit Gold^2*, Yair Herishanu, MD^1,3*, Noam Benyamini, MD^1,3*, Sigal Grisariu Greenzaid, MD^4,5*, Batia Avni^6,7*, Polina Stepensky^5,7*, Diana Libster, MD^6,8, Dana Yehudai-Ofir, MD^9,10*, Shimrit Harlev^9,10*, Liat Sharvit^10*, Tsila Zuckerman, MD^9,10, Uri Greenbaum^11*, Irit Avivi, MD^1,3* and Ron Ram, MD^1,2

¹Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Bone Marrow Transplant Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁴Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
⁵Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
⁶Department of Bone Marrow Transplantation & Cancer Immunotherapy Hadassah Medical Center Jerusalem, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁷Department of Bone Marrow Transplantation, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁸Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
⁹The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
¹⁰Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
¹¹Soroka University Medical center, Beer Sheva, Israel

Michael Dickinson, MD¹, Giuseppe Gritti^2*, Carmelo Carlo-Stella, MD, PhD³, Harriet S Walter^4*, David Carlile^5*, Nicole Getzmann^6*, Samira Curdt^7*, Emma Harrop^8*, Abiraj Keelara, PhD^9*, Koorosh Korfi, PhD^10*, Remi Labatut^10*, Francesca Michielin^10*, Sarah Louise Mycroft^11*, Tom Moore, MD^7*, Robert Nutbrown^12*, Giuseppe Palldino^13*, Matt Whayman^11*, Johannes Sam, PhD^14*, Martin Weisser, MD, PhD^15*, Katharina E Lechner^15*, Franck Morschhauser, MD, PhD^16* and Martin Hutchings, MD, PhD^17*

¹Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
²Ematologia, ASST PAPA GIOVANNI XXIII, Bergamo, ITA
³Humanitas Clinical and Research Center, Humanitas University, Milan, Italy
⁴The HOPE Clinical Trials Unit, Leicester, United Kingdom
⁵Oncology IMED Biotech Unit, Roche, Welwyn Garden City, United Kingdom
⁶Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland
⁷Roche Innovation Center Munich, Roche Pharma Research and Early Development, Munich, Germany
⁸Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn, United Kingdom
⁹Roche Innovation Center Basel,, Roche Pharma Research and Early Development, Basel, Switzerland
¹⁰Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
¹¹Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United Kingdom
¹²Roche Innovation Center Welwyn, Roche Pharama Research and Early Development, Welwyn, United Kingdom
¹³A4P Consulting Ltd., Sandwich, United Kingdom
¹⁴Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
¹⁵Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany
¹⁶Department of Hematology, University Lille, CHU Lille, EA 7365 - GRITA - Groupe de Recherche sur les forms Injectables et les Technologies Associées, Lille, France
¹⁷Department of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark

Haorui Shen, MD, PhD^1*, Jia-Zhu Wu, MD, PhD^1*, Jin-Hua Liang, MD, PhD^1*, Hua Yin, MD, PhD^1*, Li Wang^2*, Jianyong Li, MD³ and Wei Xu²

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China, Nanjing, China
²Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Marcus Geer, MD¹, Salena Kasha, A.A.^2*, David Frame, PharmD^3* and Monalisa Ghosh, MD⁴

¹Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI
²Dept of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI
³University of Michigan, Ann Arbor, MI
⁴Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI

Luis Juarez-Salcedo, MD^1*, Nicole Ianniello, PharmD^2*, Emily Coughlin, MPH^3*, Julio C. Chavez, MD⁴, Jose Sandoval-Sus, MD⁵, Samir Dalia, MD⁶ and Rahul Mhaskar, MD, MPH, PhD^3*

¹Hospital Universitario La Princesa, Madrid, Madrid, Spain
²Florida Cancer Specialists & Research Institute, Weston, FL
³University of South Florida, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Malignant Hematology and Cellular Therapy at Memorial Healthcare System, Moffitt Cancer Center, Pembroke Pines, FL
⁶Mercy Clinic, Joplin, MO

Mitchell S. Cairo, MD¹, Mark A. Rocco, PhD^2*, John Bernard, MD^2*, Satya R. Siddani, PhD^3*, Apurvasena Parikh, PhD^2*, Brian Elliott, MD⁴ and Birgit Burkhardt, MD, PhD^5*

¹New York Medical College, Valhalla, NY
²AbbVie, South San Francisco, CA
³AbbVie Inc., North Chicago, IL
⁴Genmab, Princeton, NJ
⁵University Hospital Münster, Münster, Germany

Wern Lynn Ng^1*, Allison M. Bock, MD², Iuliia Kovalenko, MD¹, Yijin Wert^3*, Lay She Ng^4*, Yucai Wang, MD, PhD⁵ and Grzegorz S. Nowakowski, MD²

¹UPMC Harrisburg, Harrisburg, PA
²Division of Hematology, Mayo Clinic, Rochester, MN
³UPMC Harrisburg, Harrisburg
⁴Royal College of Surgeons in Ireland and University College Dublin Malaysia Campus (RUMC), Penang, Malaysia
⁵Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Kamila Polgarova^1*, Andrea Janíková, assoc. prof., MD, PhD^2*, David Belada, assoc. prof., MD, PhD^3*, Vit Prochazka, Prof., MD, PhD^4*, Juraj Ďuraš, MD^5*, Heidi Móciková, MD, PhD^6*, Kateřina Steinerová, MD^7*, Vít Campr, MD^8*, Petra Blahovcová, Mgr^9*, David Zogala, MD, PhD^10*, Václav Ptáčník, MD^10* and Marek Trneny, MD¹¹

¹1st Department of Internal Medicine - Hematology, First Medical Faculty, Charles University and General University Hospital, Prague, Prague, Czech Republic
²Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
³Fourth Department of Internal Medicine – Hematology, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
⁴Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
⁵Department of Hemato-Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic
⁶Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
⁷Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
⁸Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
⁹Data Centre, Czech Lymphoma Study Group, Prague, Czech Republic
¹⁰Departement of Nuclear Medicine, Charles University and General Hospital, Prague, Czech Republic
¹¹1st Department of Internal Medicine - Hematology, General Hospital, Charles University, Prague, Czech Republic

Megan Melody, MD, MS¹, Frederique St. Pierre, MD^1*, Irene Helenowski, PhD^1*, William B Pearse, MD², Chetan Vakkalagadda, MD^1*, Joseph R. Leventhal, MD, PhD^3*, Bing Ho, MD, MPH^3*, John Friedewald, MD^3*, Daniel Ganger, MD^4*, Jane N. Winter, MD¹, Leo I. Gordon, MD¹, Adam Yuh Lin, MD, PhD¹, Reem Karmali, MD, MSc¹, Shuo Ma, MD¹, Barbara Pro, MD⁵ and Jonathan Moreira, MD¹

¹Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
²Division of Hematology and Oncology, University of California, San Diego, La Jolla, CA
³Northwestern University Medical Center, Comprehensive Transplant Center, Chicago, IL
⁴Northwestern University Medical Center, Northwestern Medicine Digestive Health Center, Chicago, IL
⁵Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

Alexandre Willaume, MD^1*, Mourtaza Karimdjee, MD^2*, Sandy Amorim, MD^3*, Benjamin Carpentier, MD^4*, Benedicte Hivert, MD^5*, Emmanuelle Bourgeois-Petit, MD^6*, Pierre Gosset, MD^7*, Alban Bailliez, MD, PhD^8* and Laurent Pascal, MD, PhD^9*

¹Université Catholique de Lille, Hôpital Saint Vincent de Paul, Lille, FRA
²Humanitep, Groupement des Hôpitaux Catholique de Lille, LOMME, France
³Hématologie clinique, Hôpital Saint Vincent de Paul, Lille, France
⁴Hopital Saint Vincent, GHICL, Lille, FRA
⁵Groupement des Hopitaux Institut Catholique de Lille, Lille, France
⁶Hematology, Hôpital Saint Vincent de Paul, Lille Cedex, FRA
⁷Hôpital Saint Vincent de Paul, Laboratoire d'Anatomo-Pathologie, Groupement des Hôpitaux Catholique de Lille, LILLE, France
⁸Hôpital Saint Philibert, Humanitep, Groupement des Hôpitaux Catholique de Lille, LOMME, France
⁹Université Catholique de Lille, Hopital Saint Vincent de Paul, Lille, FRA

Azza Ali Fahmy Ayad, MSc^1*, Reham Abdelaziz Khedr, MD^2,3, Asmaa Mohammed Hamoda, MD, PhD, MSc^4*, Tamer Diab^5*, Nahla Elnabarawy^6*, Elhamy Rifky^7*, Leslie E. Lehmann, MD^8,9,10 and Alaa M. Elhaddad, MD^11,12

¹Pediatric Oncology, Children's cancer Hospital Egypt 57357, Cairo, EGY
²Pediatric oncology, Chlidren’s Cancer Hospital Egypt 57357, Cairo, Egypt
³Pediatric oncology, National Cancer Institute - Cairo university, Cairo, Egypt
⁴National cancer Institute- Cairo University / CCHE57357, Cairo, EGY
⁵Psychology department, Children's Cancer hospital Egypt, cairo, Egypt
⁶Children's cancer hospital Egypt 57357, cairo, Egypt
⁷Children's cancer hospital 57357Egypt, cairo, Egypt
⁸Department of Pediatrics, Harvard Medical School, Boston, MA
⁹Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA
¹⁰Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
¹¹Department of Pediatric Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Cairo University, Cairo, Egypt
¹²Department of Pediatric Oncology and Stem Cell Transplantation Unit, Children Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt

Narendranath Epperla, MD, MS¹, Adam Zayac, MD², Daniel J. Landsburg, MD³, Mitchell Hughes, PharmD^3*, Allison M. Bock, MD⁴, Grzegorz S. Nowakowski, MD⁴, Emily C. Ayers, MD⁵, Mark Girton, MD^6*, Marie Hu^7*, Amy Beckman, MD^7*, Shaoying Li^8*, L. Jeffrey Medeiros, MD⁹, Julie E. Chang, MD¹⁰, Adam Stepanovic, MD^10*, Habibe Kurt, MD^11*, Jose Sandoval-Sus, MD¹², M. Ali Ansari-Lari, MD^13*, Shalin K. Kothari, MD¹⁴, Anna Kress, MD¹⁵, Mina L Xu, MD^16*, Pallawi Torka, MD¹⁷, Suchitra Sundaram, MD^18*, Stephen D Smith, MD^19*, Kikkeri N Naresh, MD, MBBS²⁰, Yasmin Karimi, MD^21*, David A. Bond, MD, BS²², Umar Farooq, MD²³, Mahak Saad, MD^23*, Andrew Matthew Evens, DO, MBA, MMSc²⁴, Karan Pandya, MD^25*, Seema G Naik, MD^26*, Manali Kamdar^27*, Bradley M. Haverkos, MD, MS, MPH²⁸, Reem Karmali, MD, MSc²⁹, Timothy S Oh, MD^30*, Julie M. Vose, MD, MBA³¹, Heather Nutsch^31*, Paul Rubinstein, MD^32*, Amina Chaudhry, MD³² and Adam J. Olszewski, MD³³

¹The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
²Department of Medicine, Englewood Health Physician Network, Englewood, NJ
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵University of Virginia, Charlottesville, VA
⁶Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA
⁷Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
⁸Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
¹¹Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, RI
¹²H Lee Moffitt Cancer Center at Memorial Cancer Institute, Ft Lauderdale, FL
¹³Department of Pathology, Hematopathology, Memorial Health System-Moffitt Cancer Center, Hollywood, FL
¹⁴Center of Molecular and Cellular Oncology and Department of Internal Medicine, Section of Hematology,, Yale University School of Medicine, New Haven, CT
¹⁵Yale University School of Medicine, New Haven, CT
¹⁶Yale University School of Medicine and Yale Cancer Center, New Haven, CT
¹⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁸Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁹Division of Medical Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA
²⁰Department of Pathology, University of Washington, Seattle, WA
²¹Division of Hematology-Oncology, University of Michigan Health, Ann Arbor, MI
²²Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
²³Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
²⁴Rutgers Cancer Institute of New Jersey, Warren, NJ
²⁵Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²⁶Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
²⁷University of Colorado School of Medicine, Denver, CO
²⁸Division of Hematology, University of Colorado, Aurora, CO
²⁹Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
³⁰Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
³¹University of Nebraska Medical Center, Omaha, NE
³²Department of Hematology-Oncology, University of Illinois-Chicago, Chicago, IL
³³Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI

Tomoyo Kubo, MD^1*, Yoshimitsu Shimomura, MD^1,2*, Hayato Maruoka, MHS^3*, Yuya Nagai, MD, PhD^1*, Tadakazu Kondo, MD, PhD¹ and Takayuki Ishikawa¹

¹Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
²Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan
³Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan

Yurou Chu^1*, Yingyue Liu^1*, Xiaosheng Fang, MD, PhD^2*, Yujie Jiang, MD², Mei Ding, MD^2*, Xueling Ge, MD^2*, Dai Yuan^2*, Kang Lu, PhD^2*, Peipei Li, PhD^2*, Ying Li, MD^2*, Hongzhi Xu, MD^2*, Juan Fan^2*, Xiangxiang Zhou, PhD^1,2* and Xin Wang^1,2

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Sarah L Beverstock^1*, Gabrielle Clark^1*, Nicole Haggarty^1*, Clare Brown^1* and Victoria Louise Campbell, BSc, FRCPath, MBBS, MRCP^2*

¹Western General Hospital, Edinburgh, United Kingdom
²Western General Hospital, Edinburgh, GBR